Dow Up 2.00% Nasdaq Up 1.66%

ArQule Inc. (ARQL)

-NasdaqGM
1.65 Down 0.01(0.60%) Feb 12, 4:00PM EST
Prev Close:1.66
Open:1.68
Bid:N/A
Ask:2.70 x 2000
1y Target Est:4.00
Beta:1.88458
Earnings Date:Mar 2 - Mar 7 (Est.)
Day's Range:1.65 - 1.69
52wk Range:1.31 - 2.65
Volume:31,497
Avg Vol (3m):94,727
Market Cap:103.77M
P/E (ttm):N/A
EPS (ttm):-0.23
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ARQL

Comparison

Symbol% ChgMkt Cap
ARQLDown 0.60%103.77M
ARRYUp 2.75%375.54M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):9.11
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.23
Quarterly EPS Est (Dec-15) :-0.06
Mean Recommendation*:2.7
PEG Ratio (5 yr expected):-1.44

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ArQule, Inc., a clinical-stage biotechnology company, researches and develops therapeutics for the treatment of cancer and rare diseases. Its lead product candidate is tivantinib, a small molecule inhibitor of the c-Met receptor tyrosine kinase an... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback